Sourced from:Manufacturer Authorized Distributor
Quick Summary
Betatinib 100mg Capsule
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹6562
MRP: ₹8344
(You Save ₹1782)
30 CAPSULE(s) IN A BOTTLE
Betatinib 100 mg Capsule is a prescription anticancer medicine used in the treatment of certain blood cancers such as chronic myeloid leukemia. It works by inhibiting abnormal protein activity responsible for cancer cell growth. Betatinib is used under strict oncologist supervision as part of targeted cancer therapy.
Sourced from:Manufacturer Authorized Distributor
21% OFF
₹6562
MRP: ₹8,344.00
Inclusive of all taxes
21% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Acaone 100mg Capsule
MSN LABORATORIE...
₹ 287.50/capsule
32% costlier
Acabrunat 100mg Capsule
NATCO PHARMA LT...
₹ 295.33/capsule
36% costlier
Acalnib 100mg Capsule
HETERO HEALTHCA...
₹ 307.03/capsule
41% costlier
Brutica 100mg Capsule
DELARC PHARMACE...
₹ 340.83/capsule
56% costlier
Introduction to Betatinib 100mg Capsule
Betatinib 100mg Capsule is an anticancer medicine containing the active constituent acalabrutinib. It belongs to a class of drugs called Bruton's tyrosine kinase (BTK) inhibitors. It is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL, and SLL are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs and the type of lymphocytes affected.
Before taking this medicine, inform your doctor if you have had recent surgery, bleeding problems, heart rhythm problems, infection, are pregnant, or are breastfeeding. It is not recommended for children and adolescents less than 18 years. This medicine can increase the risk of bleeding. Patients taking Betatinib 100mg Capsule should be monitored for signs of bleeding and should avoid taking other medications that can increase the risk of bleeding, such as blood thinners.
Uses of Betatinib 100mg Capsule
The Betatinib 100mg Capsule used in the treatment of:
- Chronic lymphocytic leukemia
- Small lymphocytic lymphoma
- Mantle cell lymphoma
Therapeutic Effects of Betatinib 100mg Capsule
The therapeutic effect of Betatinib 100mg Capsule is to inhibit the activity of Bruton's tyrosine kinase (BTK), a protein that is essential for the survival and growth of cancer cells in certain types of lymphomas and leukemias. By blocking BTK, it can help to slow down or even stop the growth and spread of cancer cells, which can lead to a reduction in tumor size, an improvement in symptoms, and a delay in disease progression.
Interaction of Betatinib 100mg Capsule with other drugs
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Betatinib 100mg Capsule and reduce effectiveness by causing undesirable side effects.
More Information about Betatinib 100mg Capsule
- Store in a refrigerator between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep it in its original packaging until it is ready to be used.
- Keep out of the reach of children and pets.
How to consume Betatinib 100mg Capsule
Betatinib 100mg Capsule is typically taken orally with or without food. The tablets should be swallowed whole and should not be crushed, chewed, or broken. The recommended dosage can vary depending on the type of cancer being treated and other factors such as your overall health and response to treatment. Do not take a double dose to make up for a missed dose.
Safety Advice for Betatinib 100mg Capsule
Breast Feeding
It is not known whether Betatinib 100mg Capsule is excreted into human breast milk, so breastfeeding women should consult a doctor before taking it.
Alcohol
Patients taking Betatinib 100mg Capsules avoid or limit their alcohol consumption, as alcohol can exacerbate certain side effects of the medication, such as fatigue and depression.
Liver
Betatinib 100mg Capsule can affect the liver, it elevates the liver enzymes (AST, ALT) in some patients taking it. In rare cases, severe liver injury or failure has been reported.
Lungs
If you have a lung disease or lung cancer and are considering treatment with Betatinib 100mg Capsule, it is important to discuss the potential benefits and risks of this medication with your healthcare provider.
Driving
Patients should always monitor their response to the Betatinib 100mg Capsule medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
Pregnancy
Betatinib 100mg Capsule is not safe during pregnancy. It can harm the developing fetus, so pregnancy should be avoided while taking this medicine.
Side Effects of Betatinib 100mg Capsule
Like all medications, Betatinib 100mg Capsules cause some side effects, although not everyone will experience them.
Serious:
- Bleeding problems (bruising or bleeding)
- Infections (pneumonia and sepsis)
- High blood pressure
- Heart problems (irregular heartbeat, and chest pain)
- Kidney failure
Common:
- Headache
- Diarrhea
- Nausea
- Fatigue
- Muscle and joint pain
- Bruising or bleeding easily
- Upper respiratory tract infection
- Rash or itching
Word of Advice
If you have been prescribed Betatinib 100mg Capsule, it is important to carefully read and understand the warnings and precautions associated with the medication. Patients require monitoring for signs of an allergic reaction. It can cause high blood pressure. Patients should check their blood pressure regularly. Report to your doctor if you develop a lesion or change in the appearance of an area on the skin. It increases the risk of infection, so patients should avoid close contact with infected persons. Patients with diabetes require close monitoring during treatment. Pregnancy and breastfeeding should be avoided during treatment. Always maintain a healthy and balanced diet to support your overall health and well-being.
FAQs about Betatinib 100mg Capsule
Q1.
Can I take Betatinib 100mg Capsule if I have a history of bleeding disorders?
Patients with a history of bleeding disorders may be at an increased risk of bleeding while taking Betatinib 100mg Capsule. Before starting treatment, your healthcare provider will evaluate your bleeding risk and may recommend additional monitoring or precautions.
Q2.
Can I take Betatinib 100mg Capsule if I have a history of heart disease?
Betatinib 100mg Capsule can cause cardiac effects, including irregular heartbeat and atrial fibrillation. Patients with a history of heart disease should be closely monitored while taking it. Your healthcare provider may recommend additional monitoring or precautions.
Q3.
What effects can Betatinib 100mg Capsule have on the blood?
Betatinib 100mg Capsule can affect your blood in several ways. It may cause a decrease in the number of red blood cells, white blood cells, and platelets. This can lead to anemia, infections, and an increased risk of bleeding. Your healthcare provider will monitor your blood counts before and during treatment.
Q4.
Can I take this medication if I have diabetes?
Patients can take Betatinib 100mg Capsule with diabetes, but it is important to monitor blood sugar levels closely while taking this medication. It can cause an increase in blood sugar levels in some patients, which may require adjustments in diabetes medications or insulin dosages.
Q5.
Can I Go for Tooth extraction while taking this medication?
Patients taking Betatinib 100mg Capsule should inform their dentist and healthcare provider if they need to have a tooth extraction or any other dental procedures. This is because it can increase the risk of bleeding, and impair wound healing. Your dentist and healthcare provider may recommend temporarily stopping treatment before the dental procedure to reduce the risk of bleeding.
Fact Box of Betatinib 100mg Capsule
Molecule name: Acalabrutinib | Therapeutic class: Antineoplastic
|
Pharmacological class: Bruton's tyrosine kinase (BTK) inhibitors | Indications: 1. Chronic lymphocytic leukemia 2. Small lymphocytic lymphoma 3. Mantle cell lymphoma
|
References
AstraZeneca, Electronica medicines compendium (EMC), [Revised on Dec 2020], [ Accessed on 5th May 2023], https://www.medicines.org.uk/emc/files/pil.11917.pdf
AstraZeneca, US Food and Drug Administration, [ Revised on Oct 2017], [ Accessed on 5th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/210259s000lbl.pdf
John C Byrd et al; Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results; Blood; Published on April 2020; [Accessed on 5th May 2023]; https://pubmed.ncbi.nlm.nih.gov/31876911/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Sakshi Anil More
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy